Journal list menu
Export Citations
Download PDFs
Issue Information
Images
no
Primary plasma cell leukaemia presenting with flower-shaped nuclei
- Page: 689
- First Published: 22 February 2021
no
Unusual morphological abnormality of neutrophils in a patient with SARS-CoV-2 infection
- Page: 690
- First Published: 17 February 2021
Covid-19: Images
no
Salmon-coloured granules in residual acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
- Page: 691
- First Published: 02 January 2021
Covid-19
Free Access
free
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
- Pages: 692-696
- First Published: 14 March 2021
Commentaries
Free Access
free
Reversing the restrictive trend in diffuse large B-cell lymphoma trial eligibility: it’s time to open the gates!
- Pages: 697-698
- First Published: 14 April 2021
Free Access
free
Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation
- Pages: 701-702
- First Published: 12 April 2021
Free Access
free
The impact of Parvovirus B19 on hereditary haemolytic anaemias
- Pages: 703-704
- First Published: 30 April 2021
Review
no
Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021
- Pages: 705-722
- First Published: 20 November 2020
Wider Perspectives
no
Skipping a step: what happened to the design of randomized clinical trials in chronic lymphocytic leukaemia?
- Pages: 723-726
- First Published: 20 November 2020
Guideline
Free Access
free
Front-line management of post-transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline
- Pages: 727-740
- First Published: 20 April 2021
Haematological malignancy - Clinical
no
Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years
- Pages: 741-749
- First Published: 14 April 2021
Open Access
oa
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study
- Pages: 750-760
- First Published: 01 March 2021
no
Ruxolitinib-combined doxorubicin-etoposide-methylprednisolone regimen as a salvage therapy for refractory/relapsed haemophagocytic lymphohistiocytosis: a single-arm, multicentre, phase 2 trial
- Pages: 761-768
- First Published: 09 February 2021
no
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group
- Pages: 769-778
- First Published: 22 February 2021
no
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial
- Pages: 779-791
- First Published: 20 April 2021
Short reports
no
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre
- Pages: 792-797
- First Published: 09 March 2021
Haematological malignancy - Biology
Short reports
Open Access
oa
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype
- Pages: 798-803
- First Published: 25 March 2021
Transplantation
no
Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab–Flu–Cy: the UK experience
- Pages: 804-813
- First Published: 14 April 2021
no
Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study
- Pages: 814-826
- First Published: 12 April 2021
Red Cells and Iron
no
Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological study
- Pages: 827-840
- First Published: 25 April 2021
Haematopoiesis
short report
no
Poor mobilization of autologous CD34+ peripheral blood stem cells in haematology patients undergoing autologous stem cell transplantation is associated with the presence of variants in genes implicated in clonal haematopoiesis of indeterminant potential
- Pages: 841-844
- First Published: 22 January 2021
Letters to the Editor
Free Access
free
Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series
- Pages: 845-848
- First Published: 22 March 2021
Free Access
free
The limited role of comprehensive staging work-up in ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALToma) with excellent prognosis
- Pages: 848-851
- First Published: 29 March 2021
Free Access
free
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy
- Pages: 851-855
- First Published: 13 March 2021
Book Review
no
Leukemia. Radiation. Chornobyl (Oncohematological Consequences of the Chornobyl Catastrophe)
- Page: 856
- First Published: 12 May 2021
Online only
Free Access
free
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities?
- Pages: e27-e31
- First Published: 11 April 2021
Free Access
free
Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure
- Pages: e33-e36
- First Published: 21 March 2021
Free Access
free
Successful treatment of solitary bone plasmacytoma and bone remineralisation with novel biological agents leading to new bone formation – a case series
- Pages: e36-e38
- First Published: 21 March 2021